The Partnership to Improve Patient Care issued the following statement in response to President Trump's State of the Union Address.
|
PIPC appreciates the administration’s goals to lower health costs for patients. PIPC remains concerned that the latest proposals to advance a Most Favored Nation pricing model for drugs will, in effect, import the worst of foreign health systems – their reliance on discriminatory value assessments. Stories from outside the U.S., like that of the Williams’ family, illustrate why quality-adjusted life years (QALYs) have no place in U.S. policy. Patients do not have the luxury of time.
PIPC shared the following statement highlighting its appreciation for the Trump Administration’s goal of lowering health care costs for patients awhile sharing continued concerns over the subjectivity and lack of transparency in the process for selecting a Maximum Fair Price (MFP), limited consideration of patient perspectives, and potential for continued reliance on value assessments conducted by the Institute for Clinical and Economic Review.
The Partnership to Improve Patient Care (PIPC) has issued the following statement in response to the Trump administration's "GENEROUS" model.
The Partnership to Improve Patient Care (PIPC) has issued the following statement in response to the Trump administration's consideration of "Most Favored Nations" policy in the U.S.
The Partnership to Improve Patient Care (PIPC) has issued the following statement calling on the Trump administration to avoid policies that discriminate against patients and people with disabilities.
The Partnership to Improve Patient Care (PIPC) has issued the following statement calling on the Trump administration to avoid policies that discriminate against patients and people with disabilities.
For Immediate Release
January 17, 2025 Today, the Partnership to Improve Patient Care (PIPC) issued a statement on the selection of drugs subject to Medicare price negotiations in 2027.
Tony Coelho’s Statement Supporting the Protecting Health Care for All Patients Act, H.R. 4851/30/2024
Today, PIPC Chairman Tony Coelho issued the following statement of support for H.R. 485, The Protecting Health Care for All Patients Act.
PIPC Statement on Selection of Drugs under Medicare Drug Price Negotiation Program Guidance8/29/2023
The Partnership to Improve Patient Care (PIPC) has issued the following statement on the Centers for Medicare and Medicaid Services' (CMS) final guidance on the Medicare Drug Price Negotiation Program.
For Immediate Release
March 23, 2023 PIPC Chairman Tony Coelho issued the following statement on H.R. 485, the Protecting Health Care for All Patients Act.
The Protecting Health Care for All Patients Act represents an important step forward to strengthen and extend existing protections against use of the quality-adjusted life year (QALY) and similar metrics to all federal programs. The bill advances recent recommendations of the National Council on Disability and reflects longstanding, bipartisan concern with use of QALY standards in health care policy.
|
